Search results
Days of Our Lives Preview: Bobby Lands in Jail and Sloan Tells Eric the Truth About Jude — Well,...
SheKnows· 3 days agoIn a Days of Our Lives for May 20-24, the Hortons are heading home! The Horton House is back!...
Days of Our Lives Spoilers for the Week of 5-20-24: The Baby Secret Starts to Come Out, But There's...
TV Fanatic· 2 days agoIt feels like it's been forever since Sloan stole Nicole's baby. Days of Our Lives often drags...
Horrible nightmares and ‘daymares’ linked to autoimmune disease
KTBS Shreveport· 6 hours agoAnother English patient described nightmares “where I can’t breathe and where someone is sitting on...
The Buzz: LSU Visits No. 1 Quarterback in America, Tigers Turning Up The Heat
Sports Illustrated· 52 minutes agoLSU continues its push for the No. 1 quarterback in the 2026 class, Faizon Brandon, with focus...
Vanguard 'nickel-and-dimes Grandma' after 49 years without junk fees
Yahoo Finance· 3 days agoVanguard has long had a reputation for eschewing the random fees asset managers are known for. But...
Days of Our Lives spoilers for Tuesday, May 21: Chad needs some help from Steve! Plus, EJ has a...
Daily Soap Dish· 19 hours agoJamie holds an associate's degree in Journalism from Broward College and is a full-time writer and...
DAYS Spoilers: EJ Lays Down the Law to Sloan
SOAPHUB via Yahoo News· 1 day agoDays of our Lives spoilers for Tuesday, May 21 find Sloan losing more and more control as, now that he knows the truth, the whole truth, and nothing but...
FDIC Chairman Martin Gruenberg to Resign Following Report Detailing Sexual Harassment at Agency
The Wall Street Journal· 19 hours agoGruenberg bowed to pressure to resign after an external investigation found widespread sexual...
Good early returns for Mayo Clinic: Income up 143% so far this year
Post-Bulletin· 2 hours agoUnlike many other hospital systems, Mayo Clinic posted very strong financial results for the first...
MIRA Pharmaceuticals in Discussions with Memorial | Newswise
Newswise· 14 hours ago(NASDAQ: MIRA) ("MIRA" or the "Company"), a pre-clinical-stage pharmaceutical company focused on the treatment of neurologic and neuropsychiatric disorders, announced it is in advanced discussions ...